.png)
Tjoapack joins Alcami in a strategic step toward a stronger global drug product CDMO platform.

Our company thrives on its inclusive culture, valuing and appreciating the diverse nationalities represented within our workforce. We believe that by embracing different backgrounds and perspectives, we create a vibrant and dynamic work environment..

Our Business Development and Marketing Officer Julia Leonteva participated in the CPHI Online panel discussion, where along with other experts she shared perspectives on sustainable packaging in the pharmaceutical industry, what are the main...

Our CEO Dexter Tjoa sat down with Pharma Manufacturing Magazine to discuss the future of drug development and manufacturing as we navigate through 2023 and beyond, with groundbreaking trends like AI technology, innovative dosage forms, and...

The Tjoapack US facility in Clinton, TN is happy to share the news about a successful Pharma FDA inspection from 26-28 June 2023.

Our Director Operations in Tjoapack Netherlands Jurgen Flohr sat down with Life Sciences Knowledge Hub to discuss the major trends in the prefilled syringe (PFS) and injection sphere — aside from patient-centricity.

The pharma industry has experienced significant changes in the past five years, with the COVID-19 pandemic and regional conflicts causing significant disruption to the supply chain of packaged drug products.

Artificial intelligence (AI), blockchain and automation have the potential to streamline the pharmaceutical packaging process and optimize traceability of finished units. The use of new packaging materials can minimise the industry’s carbon footprint

Discover profound insights from Tjoapack US President Peter Belden as he elucidates the attainment of sustainability and integrity through optimal packaging and supply chain solutions.
Ready to shape the future of your pharmaceutical supply chain?